Selection of both normal and bleeding patients is indicated before desmopressin administration

• References

• 1 Grainge C, Nokes T. Cerebral arterial thrombosis in a young woman following vasopressin for von Willebrand’s disease. Thromb Haemost 2005; 93: 380
• 2 Vandesbrouke JP, Rosing J. Bloemenkamp KW. Oral contraception and the risk of venous thrombosis. N Eng J Med 1998; 57: 203-9
• 3 Girolami A, Simioni P, Girolami B. et al The role of drugs, particularly oral contraceptives, in triggering thrombosis in congenital defects of coagulation inhibitors: a study of six patients. Blood Coagul Fibrinolysis 1991; 2: 673-8
• 4 Byrness JJ, Larcade A, Moeke JL. Thrombosis following desmopressin for anemic bleeding, Am J Haematol. 1988; 28: 63-5.
• 5 Editorial Desmopressin and thrombosis. Lancet 1989; 333: 938-9.
• 6 Van Dantzig JM, Duren DR, Ten Cate JW. Desmopressin and Myocardial Infarction. Lancet 1989; 333: 664-5
• 7 O'Brien JR, Green PJ, Salmon G. et al Desmopressin and myocardial infarction. Lancet 1989; 333: 664
• 8 Bond l, Bevan D. Myocardial infarction in a patient with hemophilia treated with DDAVP. N Engl J Med 1988; 318: 121
• 9 Hartmann S, Reinhart W. Fatal complication of desmopressin. Lancet 1995; 345: 1302-3
• 10 Virtanen R, Kauppila M, Itala M. Percutaneous coronary intervention with stenting in a patient with haemophilia A and an acute myocardial infarction following a single dose of desmopressin. Thromb Haemost 2004; 92: 1154-6
• 11 Mannucci PM. Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders. Blood 1988; 72: 1449-55